Sunshine Biopharma (NASDAQ:SBFM) Downgraded by Wall Street Zen to Sell

Retrieved on: 2025-07-19 05:54:14

Tags for this article:

Click the tags to see associated articles and topics

Sunshine Biopharma (NASDAQ:SBFM) Downgraded by Wall Street Zen to Sell. View article details on hiswai:

Excerpt

Sunshine Biopharma has a 12-month low of $1.17 and a 12-month high of $6.99. The firm has a market capitalization of $7.11 million, a price-to- ...

Article found on: www.defenseworld.net